1Ridker PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention [ J ]. Circulation, 2003,107(3) : 363-369.
2Semiz S,Rota S, Ozdemir O, et al. Are C-reactive protein and homocysteine cardiovascular risk factors in obese children and adolescents? [J]. Pediatr Int, 2008,50 (4): 419-423.
4Chiba T, Shinozaki S, Nakazawa T, et al. Leptin deficiency suppresses progression of atherosclerosis in apoE-deficient mice[J]. Atherosclerosis, 2008,196 (1) : 68-75.
5Bobbert T, Rochlitz H, Wegewitz U, et al. Changes of adiponectin oligomer composition by moderate weight reduction[J]. Diabetes,2005,54(9) :2712-2719.
6Aso Y, Yamamoto R, Wakabayashi S, et al. Comparison of serum high-molecular weight (HMW) adiponectin with total adiponectin concentrations in type 2 diabetic patients with coronary artery disease using a novel enzyme-linked immunosorbent assay to detect HMW adiponectin [J ]. Diabetes, 2006,55 ( 7 ) : 1954-1960.
7Bajnok L, Csongradi E, Seres I, et al. Relationship of adiponectin to serum paraoxonase [J]. Atherosclerosis, 2008, 197(1) :363-367.
8Araki T,Emoto M,Teramura M,et al. Effect of adiponectin on carotid arterial stiffness in type 2 diabetic patients treated with pioglitazone and metformin[J]. Metabolism, 2006,55 (8) : 996- 1001.
9Reilly MP, Lehrke M, Wolfe ML, et al. Resistin is an inflammatory marker of atheroselerosis in humans[J ]. Circulation, 2005,111(7) :932-939.
10Mertens I, van Gaal LF. Visceral fat as a determinant of fibrinolysis and hemostasis[J]. Semin Vase Med, 2005,5 ( 1 ) : 48-55.
5Petnehazy T,Stokes K Y,Russell J M,et al.AngiotensinⅡtype receptor antagonism attenuates the inflammatory and thrombogenic responses to hypercholesterolemia in venules[J].Hypertension,2005,45:209-215.
6Delbosc S,Paizanis E,Magous R,et al.Involvement of oxidative stress and NADPH oxidase activation in the development of cardiovascular complications in a model of insulin resistance,the fructose-fed rat[J].Atherosclerosis,2005,179(1):43-49.
7Antelava N,Pachkoria K Z,Kezeli T D,et al.Major pathogenic links of atheroscler-osis[J].Georgian Med News,2005,128:72-79.
8Stocker R,Keaney J F.Role of oxidative modifications in atherosclerosis[J].Physiol Rev,2004,84(4):1381-1478.
9Paulson K E,Zhu S N,Chen M,et al.Resident intimal dendritic cells accumulate lipid and contribute to the initiation of atherosclerosis[J].Circ Res,2010,106(2):283-390.
10Harrington J R.The role of MCP-1 in atherosclerosis[J].Stem Cells,2000,18(1):65-66.
